Acerta Pharma is a leader in the field of covalent binding technology who is applying this technology to create novel, highly selective therapies for cancer.

Pharmaceutical

Acerta Pharma B.V.

Acerta Pharma B.V.'s headquarters in Oss, Netherlands

Nico Stam

Jude Fitzgibbon

Martijn Bax

Anas Younes

Niko Andre

This department focuses on research and development in the fields of chemistry and biosciences, driving innovation and scientific advancement.

Chemistry and Bioscience

This department is responsible for overseeing and managing global study initiatives and ensuring their successful execution.

Global Study Operations

The Research and Development team at Acerta Pharma B.V. focuses on leveraging covalent binding technology to develop novel, highly selective therapies for cancer. This team of highly skilled scientists conducts advanced biological, bioinformatics, and translational research to identify and optimize breakthrough therapeutic compounds, aiming to improve patient outcomes in oncology.

Research and Development

This department focuses on conducting experiments and advancing knowledge in the field of chemistry.

Chemistry Research

This department focuses on the development and oversight of clinical and regulatory documentation to ensure compliance and safety in medical practices.

Clinical and Regulatory Affairs

This department focuses on the design and development of new chemical entities for therapeutic purposes.

Acerta Pharma B.V.

Org chart

Board & advisors

Teams

Chemistry and Bioscience

Global Study Operations

Research and Development

Chemistry Research

Clinical and Regulatory Affairs

Medicinal Chemistry

Offices

Acerta Pharma B.V.

Org chart

Board & advisors

Teams

Chemistry and Bioscience

Global Study Operations

Research and Development

Chemistry Research

Clinical and Regulatory Affairs

Medicinal Chemistry

Offices

Related companies